Friday, May 3, 2019

The U.S. Food and Drug Administration on Wednesday gave Sanofi SA's dengue vaccine Dengvaxia a very narrow approval as the company continues to suffer from evidence that its vaccine, which took 20 years to develop, can cause severe infections in some people.


from Reuters: Health News https://reut.rs/2IU2Q8Q

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Changing the criminal penalties for drug possession could reduce racial and ethnic disparities in the criminal justice system and indirectly reduce health disparities as well, researchers say. from Reu… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Today's moms-to-be are more likely than women from their mothers' generation to become depressed while pregnant, a study suggests. from Reuters: Health News https://ift.tt/2KRDBVO … Read More
  • LATEST HEALTH NEWSNEW YORK (Reuters Health) - There is a new epidemic of hepatitis C, HIV, and other infections within the opioid abuse epidemic, according to participants in a National Academies of Sciences, Engineering, and Medicine workshop… Read More
  • LATEST HEALTH NEWSA U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine. … Read More
  • LATEST HEALTH NEWSZogenix Inc said on Thursday its drug to treat a rare form of childhood epilepsy reduced convulsive seizures in a second late-stage trial, sending the drug developer's shares up as much as 26 percent. from Reuters: Healt… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner